IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults
This study is currently recruiting participants.
Verified March 2016 by BiondVax Pharmaceuticals ltd.
Sponsor:
BiondVax Pharmaceuticals ltd.
Collaborator:
Seventh Framework Programme
Information provided by (Responsible Party):
BiondVax Pharmaceuticals ltd.
ClinicalTrials.gov Identifier:
NCT02691130
First received: February 11, 2016
Last updated: March 15, 2016
Last verified: March 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2017 |
| Estimated Primary Completion Date: | October 2016 (Final data collection date for primary outcome measure) |